Moreover, a recent experimental study in a LDL-R+/- mouse model investigated the potential effect of a vaccine targeting PCSK9 (PCSK9Qβ-003) on hypercholesterolemia and kidney fibrosis. The gene discussed is LDLR; the disease is familial hypercholesterolemia.